Related Experiment Videos
Introduction: new technologies for genetic and newborn screening.
M R Seashore1, C Walsh-Vockley
1Department of Human Genetics, Yale University School of Medicine, New Haven, Connecticut.
The Yale Journal of Biology and Medicine
|January 1, 1991
Summary
Newborn screening for inherited disorders prevents serious health issues. Advances in genetic screening will expand to populations, necessitating policy discussions on financial, legal, and ethical implications.
Area of Science:
- Medical Genetics
- Public Health Policy
- Bioethics
Background:
- Newborn screening for inherited metabolic disorders has successfully prevented severe health outcomes for over 20 years.
- Technological advancements are expanding screening capabilities beyond newborns to broader population genetic risk assessment.
Purpose of the Study:
- To address the financial, legal, and ethical considerations arising from expanded genetic screening.
- To inform the development of public policies for effective implementation of genetic screening technologies.
Main Methods:
- The study is based on discussions and findings from a conference.
- The conference convened health care practitioners, health policy planners, and public health professionals.
Main Results:
- The conference highlighted the critical need to consider financial, legal, and ethical issues.
- Effective public policy development is essential to maximize the benefits of advanced screening techniques.
Conclusions:
- Expanding genetic screening necessitates proactive policy development to manage associated challenges.
- Integrating financial, legal, and ethical frameworks is crucial for the responsible advancement of population-level genetic risk assessment.